You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Randomized Controlled Trials as Topic

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Cardiac Surgery Trial (Early diet resumption)

Not yet recruiting
  • Adult Cardiac Surgery
  • Early diet resumption
  • (no location specified)
Nov 19, 2023

Amputation, Amputation; Postoperative, Sequelae, Wound Dehiscence Trial in Italy, United States (PREVENA™ PEEL & PLACE™ Dressing

Recruiting
  • Amputation
  • +5 more
  • PREVENA™ PEEL & PLACE™ Dressing Kit
  • Valhalla, New York
  • +3 more
Nov 3, 2021

Elbow Fracture, Trauma Trial in South Brisbane, Vancouver (Long arm soft cast, Long arm full cast)

Recruiting
  • Elbow Fracture
  • Trauma
  • Long arm soft cast
  • Long arm full cast
  • South Brisbane, Australia
  • +1 more
May 16, 2022

Vitreoretinopathy, Coats' Disease, Exudative Retinopathy Trial in Durham (Dextenza 0.4Mg Ophthalmic Insert, Pred Forte)

Not yet recruiting
  • Vitreoretinopathy
  • +8 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • Pred Forte
  • Durham, North Carolina
    Duke Eye Center
Nov 10, 2022

MDD Trial in New York (SEP-363856, Placebo)

Recruiting
  • Major Depressive Disorder
  • New York, New York
    For additional information regarding sites, contact 844-687-8522
Nov 14, 2022

Healthy Adult Trial in Melbourne (SON-1010 (IL12-FHAB))

Recruiting
  • Healthy Adult
  • SON-1010 (IL12-FHAB)
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Oct 26, 2022

Prostate Cancer Trial in Worldwide (Abiraterone, Apitolisib, Ipatasertib)

Completed
  • Prostate Cancer
  • Scottsdale, Arizona
  • +58 more
Sep 7, 2022

Tuberculosis, Tuberculosis, Pulmonary Trial in Kampala (User-Centered Implementation Strategy, Standard Implementation Strategy)

Enrolling by invitation
  • Tuberculosis
  • Tuberculosis, Pulmonary
  • User-Centered Implementation Strategy
  • Standard Implementation Strategy
  • Kampala, Uganda
    Uganda Tuberculosis Implementation Research Consortium
Nov 28, 2022

GIST Trial (Ripretinib, Sunitinib)

Not yet recruiting
  • GIST
  • (no location specified)
Feb 8, 2023

Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))

Recruiting
  • Malignant Solid Neoplasms
  • Nilotinib (400 mg BID)
  • +6 more
  • Bordeaux, France
  • +6 more
Dec 15, 2022

Health Care Disparities Trial in Durham (Shared decision making tip sheet)

Not yet recruiting
  • Health Care Disparities
  • Shared decision making tip sheet
  • Durham, North Carolina
    Duke University Medical Center
Jan 24, 2023

Colorectal Cancer Metastatic, Myelosuppression-Adult, Chemotherapeutic Toxicity Trial in Worldwide (Trilaciclib, Placebo)

Active, not recruiting
  • Colorectal Cancer Metastatic
  • +2 more
  • Tucson, Arizona
  • +81 more
Jan 3, 2023

Prader-Willi Syndrome Trial in United States (RAD011, Placebo)

Terminated
  • Prader-Willi Syndrome
  • Los Angeles, California
  • +7 more
Dec 5, 2022

Healthy Trial in Darmstadt (Tepotinib test (Treatment Period 1), Tepotinib reference (Treatment Period 2), Tepotinib reference

Completed
Has Results
  • Healthy
  • Tepotinib test (Treatment Period 1)
  • +3 more
  • Darmstadt, Germany
    For Recruiting Locations outside US, please Contact Merck KGaA C
Aug 22, 2022

PTSD, Post-traumatic Stress Disorder Trial in London (Deep Brain Reorienting (DBR))

Recruiting
  • PTSD
  • Post-traumatic Stress Disorder
  • Deep Brain Reorienting (DBR)
  • London, Ontario, Canada
    London Health Sciences Centre - University Hospital
Oct 20, 2022

Healthy Trial in Parma (Bergamot Juice)

Recruiting
  • Healthy
  • Bergamot Juice
  • Parma, Italy
    University of Parma, Department of Medicine and Surgery
Oct 18, 2022

Vertigo, BPPV, Meniere Disease Trial in Washington (Otoband Experimental, Otoband Sham)

Recruiting
  • Vertigo
  • +7 more
  • Otoband Experimental
  • Otoband Sham
  • Washington, District of Columbia
    Otolith Labs
Jul 21, 2023

Recovery From Acute Immune Failure in Septic Shock by Immune

Recruiting
  • Severe Sepsis
    • Magdeburg, Germany
    • +1 more
    Nov 20, 2023

    NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic

    Recruiting
    • NSCLC, Stage III
    • Durvalumab Injection [Imfinzi]
    • +2 more
    • Aachen, Germany
    • +13 more
    Nov 29, 2022

    Cycloplegia Trial in Amman (Cyclopentolate, Tropicamide)

    Completed
    • Cycloplegia
    • Amman, Jordan
      Islamic Hospital
    Jun 28, 2022

    Osteomyelitis, Septic Arthritis, Bone Infection Trial in Copenhagen (Oral co-amoxiclav or oral dicloxacillin only, IV ceftriaxon

    Recruiting
    • Osteomyelitis
    • +4 more
    • Oral co-amoxiclav or oral dicloxacillin only
    • IV ceftriaxon followed by oral co-amoxiclav or oral dicloxacillin
    • Copenhagen, Denmark
      Copenhagen University Hospital, Rigshospitalet
    Jun 29, 2022

    Insulin Resistance, Obesity Trial in Tübingen (single bout of moderate intensity continuous training (MICT), single bout of High

    Not yet recruiting
    • Insulin Resistance
    • Obesity
    • single bout of moderate intensity continuous training (MICT)
    • +2 more
    • Tübingen, Germany
      University Clinic Tübingen, Department of Internal Medicine IV
    Sep 13, 2023

    Chronic Hepatitis b Trial (RBD1016, RBD1016+PegIFN-a)

    Not yet recruiting
    • Chronic Hepatitis b
    • (no location specified)
    Jul 25, 2023

    Hemolysis Trial in Kayseri (Video based education, Face to face education)

    Completed
    • Hemolysis
    • Video based education
    • Face to face education
    • Kayseri, Talas, Turkey
      Kayseri Dialysis Center
    Jul 24, 2023

    HIV Trial (Method of PrEP delivery and consultation)

    Not yet recruiting
    • HIV Infections
    • Method of PrEP delivery and consultation
    • (no location specified)
    Jun 14, 2023